Analyze Diet
Virology2011; 412(2); 366-377; doi: 10.1016/j.virol.2011.01.025

The UL4 protein of equine herpesvirus 1 is not essential for replication or pathogenesis and inhibits gene expression controlled by viral and heterologous promoters.

Abstract: Defective interfering particles (DIP) of equine herpesvirus 1 (EHV-1) inhibit standard virus replication and mediate persistent infection. The DIP genome is comprised of only three genes: UL3, UL4, and a hybrid gene composed of portions of the IR4 (EICP22) and UL5 (EICP27) genes. The hybrid gene is important for DIP interference, but the function(s) of the UL3 and UL4 genes are unknown. Here, we show that UL4 is an early gene activated solely by the immediate early protein. The UL4 protein (UL4P) was detected at 4hours post-infection, was localized throughout the nucleus and cytoplasm, and was not present in purified virions. EHV-1 lacking UL4P expression was infectious and displayed cell tropism and pathogenic properties in the mouse model similar to those of parental and revertant viruses. Reporter assays demonstrated that the UL4P has a broad inhibitory function, suggesting a potential role in establishing and/or maintaining DIP-mediated persistent infection.
Publication Date: 2011-02-15 PubMed ID: 21324502PubMed Central: PMC3060994DOI: 10.1016/j.virol.2011.01.025Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • N.I.H.
  • Extramural

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the role of the UL4 protein in equine herpesvirus 1 (EHV-1), finding it unnecessary for the virus’s replication or pathogenesis and having an inhibitory effect on gene expression.

The Role and Impact of the UL4 Protein

  • Often found in defective interfering particles (DIPs) of equine herpesvirus 1 (EHV-1), the UL4 protein, also known as UL4P, had an unknown function prior to this research.
  • This research reveals that UL4P acts as an early gene that is activated purely by the immediate early protein. It is detected four hours after infection and is located throughout the cellular nucleus and cytoplasm.
  • The UL4 protein was not seen in purified virions, suggesting that it is not incorporated into viral particles.

UL4 Protein and Virus Replication and Pathogenesis

  • The research demonstrates that even in the absence of UL4P expression, EHV-1 remains infectious. This indicates that UL4P is not an essential part of the virus’s replication process.
  • Even without UL4P, the virus displayed similar levels of cell tropism and pathogenic properties when examined in a mouse model, as compared to parental and revertant viruses.

Inhibitory Function of the UL4 Protein

  • The research finds that the UL4P broadly inhibits gene expression, demonstrating its operating role and effects on the virus.
  • This inhibitory function of the UL4 protein could point to a potential role it plays in establishing and/or maintaining DIP-mediated persistent infection.
  • However, the exact method and extent of this inhibitory role, especially in regard to its potential for aiding persistent infection, needs further investigation.

Cite This Article

APA
Charvat RA, Breitenbach JE, Ahn B, Zhang Y, O'Callaghan DJ. (2011). The UL4 protein of equine herpesvirus 1 is not essential for replication or pathogenesis and inhibits gene expression controlled by viral and heterologous promoters. Virology, 412(2), 366-377. https://doi.org/10.1016/j.virol.2011.01.025

Publication

ISSN: 1096-0341
NlmUniqueID: 0110674
Country: United States
Language: English
Volume: 412
Issue: 2
Pages: 366-377

Researcher Affiliations

Charvat, Robert A
  • Center for Molecular and Tumor Virology, Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130-3932, USA.
Breitenbach, Jonathan E
    Ahn, ByungChul
      Zhang, Yunfei
        O'Callaghan, Dennis J

          MeSH Terms

          • Animals
          • Cell Line
          • Cell Nucleus / chemistry
          • Chlorocebus aethiops
          • Cytoplasm / chemistry
          • Gene Expression Regulation
          • Herpesvirus 1, Equid / pathogenicity
          • Herpesvirus 1, Equid / physiology
          • Host-Pathogen Interactions
          • Humans
          • Mice
          • Promoter Regions, Genetic
          • Rabbits
          • Viral Proteins / metabolism
          • Virus Replication

          Grant Funding

          • R01 AI022001 / NIAID NIH HHS
          • P20 RR018724-08 / NCRR NIH HHS
          • P20 RR018724 / NCRR NIH HHS
          • R01 AI022001-22 / NIAID NIH HHS
          • AI-22001 / NIAID NIH HHS
          • P20-RR018724 / NCRR NIH HHS

          References

          This article includes 65 references
          1. Ahn BC, Breitenbach JE, Kim SK, O'Callaghan DJ. The equine herpesvirus-1 IR3 gene that lies antisense to the sole immediate-early (IE) gene is trans-activated by the IE protein, and is poorly expressed to a protein.. Virology 2007 Jun 20;363(1):15-25.
            pmc: PMC1939811pubmed: 17306852doi: 10.1016/j.virol.2007.01.024google scholar: lookup
          2. Ahn BC, Zhang Y, O'Callaghan DJ. The equine herpesvirus-1 (EHV-1) IR3 transcript downregulates expression of the IE gene and the absence of IR3 gene expression alters EHV-1 biological properties and virulence.. Virology 2010 Jul 5;402(2):327-37.
            pmc: PMC3020145pubmed: 20417949doi: 10.1016/j.virol.2010.03.051google scholar: lookup
          3. Albrecht RA, Kim SK, Zhang Y, Zhao Y, O'Callaghan DJ. The equine herpesvirus 1 EICP27 protein enhances gene expression via an interaction with TATA box-binding protein.. Virology 2004 Jul 1;324(2):311-26.
            pubmed: 15207618doi: 10.1016/j.virol.2004.03.040google scholar: lookup
          4. Allen GP, Bryans JT. Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections.. Prog Vet Microbiol Immunol 1986;2:78-144.
            pubmed: 2856183
          5. Baumann RP, Dauenhauer SA, Caughman GB, Staczek J, O'Callaghan DJ. Structure and genetic complexity of the genomes of herpesvirus defective-interfering particles associated with oncogenic transformation and persistent infection.. J Virol 1984 Apr;50(1):13-21.
            pmc: PMC255575pubmed: 6321784doi: 10.1128/jvi.50.1.13-21.1984google scholar: lookup
          6. Baumann RP, Staczek J, O'Callaghan DJ. Cloning and fine mapping the DNA of equine herpesvirus type one defective interfering particles.. Virology 1986 Sep;153(2):188-200.
            pubmed: 3016989doi: 10.1016/0042-6822(86)90022-xgoogle scholar: lookup
          7. Block T, Jordan R, Farkas DH, Hughes RG Jr. Inhibition of transient gene expression with plasmids encoding herpes simplex virus type 1 UL55 and alpha genes.. J Gen Virol 1991 Jan;72 ( Pt 1):131-41.
            pubmed: 1846642doi: 10.1099/0022-1317-72-1-131google scholar: lookup
          8. Bowles DE, Holden VR, Zhao Y, O'Callaghan DJ. The ICP0 protein of equine herpesvirus 1 is an early protein that independently transactivates expression of all classes of viral promoters.. J Virol 1997 Jul;71(7):4904-14.
          9. Bowles DE, Kim SK, O'Callaghan DJ. Characterization of the trans-activation properties of equine herpesvirus 1 EICP0 protein.. J Virol 2000 Feb;74(3):1200-8.
          10. Breitenbach JE, Ebner PD, O'Callaghan DJ. The IR4 auxiliary regulatory protein expands the in vitro host range of equine herpesvirus 1 and is essential for pathogenesis in the murine model.. Virology 2009 Jan 20;383(2):188-94.
            pmc: PMC2655125pubmed: 19012943doi: 10.1016/j.virol.2008.10.017google scholar: lookup
          11. Campbell DE, Kemp MC, Perdue ML, Randall CC, Gentry GA. Equine herpesvirus in vivo: cyclic production of a DNA density variant with repetitive sequences.. Virology 1976 Feb;69(2):737-50.
            pubmed: 176793doi: 10.1016/0042-6822(76)90502-xgoogle scholar: lookup
          12. Caughman GB, Staczek J, O'Callaghan DJ. Equine herpesvirus type 1 infected cell polypeptides: evidence for immediate early/early/late regulation of viral gene expression.. Virology 1985 Aug;145(1):49-61.
            pubmed: 2990102doi: 10.1016/0042-6822(85)90200-4google scholar: lookup
          13. Chen M, Garko-Buczynski KA, Zhang Y, O'Callaghan DJ. The defective interfering particles of equine herpesvirus 1 encode an ICP22/ICP27 hybrid protein that alters viral gene regulation.. Virus Res 1999 Feb;59(2):149-64.
            pubmed: 10082387doi: 10.1016/s0168-1702(98)00128-2google scholar: lookup
          14. Chen M, Harty RN, Zhao Y, Holden VR, O'Callaghan DJ. Expression of an equine herpesvirus 1 ICP22/ICP27 hybrid protein encoded by defective interfering particles associated with persistent infection.. J Virol 1996 Jan;70(1):313-20.
            pmc: PMC189819pubmed: 8523542doi: 10.1128/jvi.70.1.313-320.1996google scholar: lookup
          15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.. Anal Biochem 1987 Apr;162(1):156-9.
            pubmed: 2440339doi: 10.1006/abio.1987.9999google scholar: lookup
          16. Colle CF 3rd, Tarbet EB, Grafton WD, Jennings SR, O'Callaghan DJ. Equine herpesvirus-1 strain KyA, a candidate vaccine strain, reduces viral titers in mice challenged with a pathogenic strain, RacL.. Virus Res 1996 Aug;43(2):111-24.
            pubmed: 8864201doi: 10.1016/0168-1702(96)01324-xgoogle scholar: lookup
          17. Csellner H, Walker C, Wellington JE, McLure LE, Love DN, Whalley JM. EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice.. Arch Virol 2000;145(11):2371-85.
            pubmed: 11205124doi: 10.1007/s007050070027google scholar: lookup
          18. Dauenhauer SA, Robinson RA, O'Callaghan DJ. Chronic production of defective-interfering particles by hamster embryo cultures of herpesvirus persistently infected and oncogenically transformed cells.. J Gen Virol 1982 May;60(Pt 1):1-14.
            pubmed: 6178795doi: 10.1099/0022-1317-60-1-1google scholar: lookup
          19. Ebner PD, Kim SK, O'Callaghan DJ. Biological and genotypic properties of defective interfering particles of equine herpesvirus 1 that mediate persistent infection.. Virology 2008 Nov 10;381(1):98-105.
            pmc: PMC2636567pubmed: 18805562doi: 10.1016/j.virol.2008.08.024google scholar: lookup
          20. Ebner PD, O'Callaghan DJ. Genetic complexity of EHV-1 defective interfering particles and identification of novel IR4/UL5 hybrid proteins produced during persistent infection.. Virus Genes 2006 Jun;32(3):313-20.
            pubmed: 16732484doi: 10.1007/s11262-005-6916-ygoogle scholar: lookup
          21. Elliott G, O'Hare P. Equine herpesvirus 1 gene 12, the functional homologue of herpes simplex virus VP16, transactivates via octamer sequences in the equine herpesvirus IE gene promoter.. Virology 1995 Oct 20;213(1):258-62.
            pubmed: 7483272doi: 10.1006/viro.1995.1568google scholar: lookup
          22. Flowers CC, O'Callaghan DJ. Equine herpesvirus 1 glycoprotein D: mapping of the transcript and a neutralization epitope.. J Virol 1992 Nov;66(11):6451-60.
          23. Frampton AR Jr, Goins WF, Cohen JB, von Einem J, Osterrieder N, O'Callaghan DJ, Glorioso JC. Equine herpesvirus 1 utilizes a novel herpesvirus entry receptor.. J Virol 2005 Mar;79(5):3169-73.
          24. Frampton AR Jr, Smith PM, Zhang Y, Grafton WD, Matsumura T, Osterrieder N, O'Callaghan DJ. Meningoencephalitis in mice infected with an equine herpesvirus 1 strain KyA recombinant expressing glycoprotein I and glycoprotein E.. Virus Genes 2004 Aug;29(1):9-17.
          25. Frampton AR Jr, Smith PM, Zhang Y, Matsumura T, Osterrieder N, O'Callaghan DJ. Contribution of gene products encoded within the unique short segment of equine herpesvirus 1 to virulence in a murine model.. Virus Res 2002 Dec;90(1-2):287-301.
            pubmed: 12457983doi: 10.1016/s0168-1702(02)00245-9google scholar: lookup
          26. Gray WL, Baumann RP, Robertson AT, Caughman GB, O'Callaghan DJ, Staczek J. Regulation of equine herpesvirus type 1 gene expression: characterization of immediate early, early, and late transcription.. Virology 1987 May;158(1):79-87.
            pubmed: 3033896doi: 10.1016/0042-6822(87)90240-6google scholar: lookup
          27. Gray WL, Yalamanchili R, Raengsakulrach B, Baumann RP, Staczek J, O'Callaghan DJ. Viral transcripts in cells infected with defective interfering particles of equine herpesvirus type 1.. Virology 1989 Sep;172(1):1-10.
            pubmed: 2549705doi: 10.1016/0042-6822(89)90101-3google scholar: lookup
          28. Grundy FJ, Baumann RP, O'Callaghan DJ. DNA sequence and comparative analyses of the equine herpesvirus type 1 immediate early gene.. Virology 1989 Sep;172(1):223-36.
            pubmed: 2549711doi: 10.1016/0042-6822(89)90124-4google scholar: lookup
          29. Harty RN, Holden VR, O'Callaghan DJ. Transcriptional and translational analyses of the UL2 gene of equine herpesvirus 1: a homolog of UL55 of herpes simplex virus type 1 that is maintained in the genome of defective interfering particles.. J Virol 1993 Apr;67(4):2255-65.
          30. Harty RN, O'Callaghan DJ. An early gene maps within and is 3' coterminal with the immediate-early gene of equine herpesvirus 1.. J Virol 1991 Jul;65(7):3829-38.
          31. Holden VR, Harty RN, Yalamanchili RR, O'Callaghan DJ. The IR3 gene of equine herpesvirus type 1: a unique gene regulated by sequences within the intron of the immediate-early gene.. DNA Seq 1992;3(3):143-52.
            pubmed: 1335300doi: 10.3109/10425179209034010google scholar: lookup
          32. Holden VR, Zhao Y, Thompson Y, Caughman GB, Smith RH, O'Callaghan DJ. Characterization of the regulatory function of the ICP22 protein of equine herpesvirus type 1.. Virology 1995 Jul 10;210(2):273-82.
            pubmed: 7618267doi: 10.1006/viro.1995.1344google scholar: lookup
          33. Huang AS, Baltimore D. Defective viral particles and viral disease processes.. Nature 1970 Apr 25;226(5243):325-7.
            pubmed: 5439728doi: 10.1038/226325a0google scholar: lookup
          34. Jang HK, Albrecht RA, Buczynski KA, Kim SK, Derbigny WA, O'Callaghan DJ. Mapping the sequences that mediate interaction of the equine herpesvirus 1 immediate-early protein and human TFIIB.. J Virol 2001 Nov;75(21):10219-30.
          35. Kim SK, Ahn BC, Albrecht RA, O'Callaghan DJ. The unique IR2 protein of equine herpesvirus 1 negatively regulates viral gene expression.. J Virol 2006 May;80(10):5041-9.
          36. Kim SK, Bowles DE, O'callaghan DJ. The gamma2 late glycoprotein K promoter of equine herpesvirus 1 is differentially regulated by the IE and EICP0 proteins.. Virology 1999 Apr 10;256(2):173-9.
            pubmed: 10191181doi: 10.1006/viro.1999.9608google scholar: lookup
          37. Kim SK, Holden VR, O'Callaghan DJ. The ICP22 protein of equine herpesvirus 1 cooperates with the IE protein to regulate viral gene expression.. J Virol 1997 Feb;71(2):1004-12.
          38. Kim SK, O'Callaghan DJ. Molecular characterizations of the equine herpesvirus 1 ETIF promoter region and translation initiation site.. Virology 2001 Jul 20;286(1):237-47.
            pubmed: 11448176doi: 10.1006/viro.2001.0988google scholar: lookup
          39. Lewis JB, Thompson YG, Caughman GB. Transcriptional control of the equine herpesvirus 1 immediate early gene.. Virology 1993 Dec;197(2):788-92.
            pubmed: 8249301doi: 10.1006/viro.1993.1658google scholar: lookup
          40. Lewis JB, Thompson YG, Feng X, Holden VR, O'Callaghan D, Caughman GB. Structural and antigenic identification of the ORF12 protein (alpha TIF) of equine herpesvirus 1.. Virology 1997 Apr 14;230(2):369-75.
            pubmed: 9143293doi: 10.1006/viro.1997.8477google scholar: lookup
          41. Lewis JB, Thompson YG, Jenkins AC, Caughman GB. Characterization and localization of the equine herpesvirus 1 major DNA binding protein.. Virology 1995 Mar 10;207(2):380-91.
            pubmed: 7886942doi: 10.1006/viro.1995.1097google scholar: lookup
          42. Matsumura T, O'Callaghan DJ, Kondo T, Kamada M. Lack of virulence of the murine fibroblast adapted strain, Kentucky A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses.. Vet Microbiol 1996 Feb;48(3-4):353-65.
            pubmed: 9054131doi: 10.1016/0378-1135(09)59999-3google scholar: lookup
          43. Mettenleiter TC, Keil GM, Fuchs W. Molecular Biology of Animal Herpesviruses. In: Mettenleiter TC, Sobrino F, editors. Animal Viruses: Molecular Biology. Caister Academic Press; Norfolk, UK: 2008. pp. 375–455.
          44. Misra V, Bratanich AC, Carpenter D, O'Hare P. Protein and DNA elements involved in transactivation of the promoter of the bovine herpesvirus (BHV) 1 IE-1 transcription unit by the BHV alpha gene trans-inducing factor.. J Virol 1994 Aug;68(8):4898-909.
          45. Moriuchi H, Moriuchi M, Cohen JI. Proteins and cis-acting elements associated with transactivation of the varicella-zoster virus (VZV) immediate-early gene 62 promoter by VZV open reading frame 10 protein.. J Virol 1995 Aug;69(8):4693-701.
          46. Muramatsu M, Smetana K, Busch H. Quantitative aspects of isolation of nucleoli of the Walker carcinosarcoma and liver of the rat. Cancer Res 1963;23:510–8.
          47. O’Callaghan DJ, Osterrieder N. Herpesviruses of Horses. In: Mahy BWJ, VanRegenmortel MHV, editors. Encyclopedia of Virology. Third. Vol. 2. Elsevier Ltd; Oxford: 2008. pp. 411–420.
          48. O'Callaghan DJ, Randall CC. Molecular anatomy of herpesviruses: recent studies.. Prog Med Virol 1976;22:152-210.
            pubmed: 790470
          49. Osterrieder N, Holden VR, Brandmüller C, Neubauer A, Kaaden OR, O'Callaghan DJ. The equine herpesvirus 1 IR6 protein is nonessential for virus growth in vitro and modified by serial virus passage in cell culture.. Virology 1996 Mar 15;217(2):442-51.
            pubmed: 8610435doi: 10.1006/viro.1996.0138google scholar: lookup
          50. Perdue ML, Kemp MC, Randall CC, O'Callaghan DJ. Studies of the molecular anatomy of the L-M cell strain of equine herpes virus type 1: proteins of the nucleocapsid and intact virion.. Virology 1974 May;59(1):201-16.
            pubmed: 4826204doi: 10.1016/0042-6822(74)90216-5google scholar: lookup
          51. Poffenberger KL, Raichlen PE, Herman RC. In vitro characterization of a herpes simplex virus type 1 ICP22 deletion mutant.. Virus Genes 1993 Jun;7(2):171-86.
            pubmed: 8396283doi: 10.1007/bf01702397google scholar: lookup
          52. Post LE, Roizman B. A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth.. Cell 1981 Jul;25(1):227-32.
            pubmed: 6268303doi: 10.1016/0092-8674(81)90247-6google scholar: lookup
          53. Purewal AS, Allsopp R, Riggio M, Telford EA, Azam S, Davison AJ, Edington N. Equid herpesviruses 1 and 4 encode functional homologs of the herpes simplex virus type 1 virion transactivator protein, VP16.. Virology 1994 Jan;198(1):385-9.
            pubmed: 8259676doi: 10.1006/viro.1994.1047google scholar: lookup
          54. Rudolph J, O'Callaghan DJ, Osterrieder N. Cloning of the genomes of equine herpesvirus type 1 (EHV-1) strains KyA and racL11 as bacterial artificial chromosomes (BAC).. J Vet Med B Infect Dis Vet Public Health 2002 Feb;49(1):31-6.
          55. Sambrook J, F EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2. Cold Springs Harbor Laboratory Press; Cold Springs Harbor, NY: 1989.
          56. Smith PM, Kahan SM, Rorex CB, von Einem J, Osterrieder N, O'Callaghan DJ. Expression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1) completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA mice.. J Virol 2005 Apr;79(8):5105-15.
          57. Smith PM, Zhang Y, Grafton WD, Jennings SR, O'Callaghan DJ. Severe murine lung immunopathology elicited by the pathogenic equine herpesvirus 1 strain RacL11 correlates with early production of macrophage inflammatory proteins 1alpha, 1beta, and 2 and tumor necrosis factor alpha.. J Virol 2000 Nov;74(21):10034-40.
          58. Smith RH, Caughman GB, O'Callaghan DJ. Characterization of the regulatory functions of the equine herpesvirus 1 immediate-early gene product.. J Virol 1992 Feb;66(2):936-45.
            pmc: PMC240795pubmed: 1309921doi: 10.1128/jvi.66.2.936-945.1992google scholar: lookup
          59. Smith RH, Zhao Y, O'Callaghan DJ. The equine herpesvirus type 1 immediate-early gene product contains an acidic transcriptional activation domain.. Virology 1994 Aug 1;202(2):760-70.
            pubmed: 8030239doi: 10.1006/viro.1994.1398google scholar: lookup
          60. von Einem J, Schumacher D, O'Callaghan DJ, Osterrieder N. The alpha-TIF (VP16) homologue (ETIF) of equine herpesvirus 1 is essential for secondary envelopment and virus egress.. J Virol 2006 Mar;80(6):2609-20.
          61. von Einem J, Wellington J, Whalley JM, Osterrieder K, O'Callaghan DJ, Osterrieder N. The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11.. J Virol 2004 Mar;78(6):3003-13.
          62. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG. Simple and highly efficient BAC recombineering using galK selection.. Nucleic Acids Res 2005 Feb 24;33(4):e36.
            pmc: PMC549575pubmed: 15731329doi: 10.1093/nar/gni035google scholar: lookup
          63. Yamada H, Jiang YM, Oshima S, Daikoku T, Yamashita Y, Tsurumi T, Nishiyama Y. Characterization of the UL55 gene product of herpes simplex virus type 2.. J Gen Virol 1998 Aug;79 ( Pt 8):1989-95.
            pubmed: 9714248doi: 10.1099/0022-1317-79-8-1989google scholar: lookup
          64. Zhang Z, Rowe J, Wang W, Sommer M, Arvin A, Moffat J, Zhu H. Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system.. J Virol 2007 Sep;81(17):9024-33.
            pmc: PMC1951468pubmed: 17581997doi: 10.1128/jvi.02666-06google scholar: lookup
          65. Zhao Y, Holden VR, Smith RH, O'Callaghan DJ. Regulatory function of the equine herpesvirus 1 ICP27 gene product.. J Virol 1995 May;69(5):2786-93.

          Citations

          This article has been cited 6 times.
          1. Zhang Y, Charvat RA, Kim SK, O'Callaghan DJ. The EHV-1 UL4 protein that tempers viral gene expression interacts with cellular transcription factors.. Virology 2014 Jan 20;449:25-34.
            doi: 10.1016/j.virol.2013.11.005pubmed: 24418534google scholar: lookup
          2. Charvat RA, Zhang Y, O'Callaghan DJ. Deletion of the UL4 gene sequence of equine herpesvirus 1 precludes the generation of defective interfering particles.. Virus Genes 2012 Oct;45(2):295-303.
            doi: 10.1007/s11262-012-0781-2pubmed: 22752566google scholar: lookup
          3. Kim S, Ahn BC, O'Callaghan DJ, Kim SK. The early UL31 gene of equine herpesvirus 1 encodes a single-stranded DNA-binding protein that has a nuclear localization signal sequence at the C-terminus.. Virology 2012 Oct 25;432(2):306-15.
            doi: 10.1016/j.virol.2012.05.031pubmed: 22721961google scholar: lookup
          4. Kim S, Dai G, O'Callaghan DJ, Kim SK. Characterization of cis-acting elements required for autorepression of the equine herpesvirus 1 IE gene.. Virus Res 2012 Apr;165(1):52-60.
          5. Ahn BC, Kim S, Zhang Y, Charvat RA, O'Callaghan DJ. The early UL3 gene of equine herpesvirus-1 encodes a tegument protein not essential for replication or virulence in the mouse.. Virology 2011 Nov 10;420(1):20-31.
            doi: 10.1016/j.virol.2011.08.016pubmed: 21917286google scholar: lookup
          6. Kim SK, Kim S, Dai G, Zhang Y, Ahn BC, O'Callaghan DJ. Identification of functional domains of the IR2 protein of equine herpesvirus 1 required for inhibition of viral gene expression and replication.. Virology 2011 Sep 1;417(2):430-42.
            doi: 10.1016/j.virol.2011.06.023pubmed: 21794889google scholar: lookup